Hair and Nail Manifestations of COVID-19

    January 2022 in “ Journal of Cosmetic Dermatology
    Antonella Tammaro, Ganiyat Adenike Ralitsa Adebanjo, Francesca Romana Parisella, Fabiola Luzi, Alessandra Scarabello
    Image of study
    TLDR COVID-19 can cause hair loss and nail changes in some patients.
    The review titled "Hair and nail manifestations of COVID‐19" discusses the dermatologic effects of COVID-19 on hair and nails. The study reports that out of 1136 patients who experienced hair loss after contracting COVID-19, 958 patients suffered from telogen effluvium (TE) with a female to male ratio of 3.86:1, two female patients experienced anagen effluvium, and 176 people had alopecia areata with a female to male ratio of 19:3. Additionally, 10 patients (6 women and 4 men) reported changes in their nails after the infection. This suggests that COVID-19 can be associated with hair and nail manifestations, which could help in understanding the clinical implications and pathophysiology of the disease.
    Discuss this study in the Community →

    Research cited in this study

    26 / 26 results

    Related Community Posts Join

    6 / 643 results

      community The amazing fast pace of PP405.

      in Chat  327 upvotes 3 months ago
      PP405 is a new hair loss treatment advancing quickly in trials, generating excitement and skepticism about its effectiveness and marketing claims. Some see it as a potential alternative to minoxidil and finasteride, but concerns about long-term effects and the need for DHT blockers persist.

      community Hair loss over a year following depression and taking antidepressants

      in Side effects?  198 upvotes 1 week ago
      A 33-year-old experienced significant hair loss after a depressive episode and taking paroxetine, possibly due to telogen effluvium or androgenic alopecia. Suggestions included reducing alcohol, considering finasteride and minoxidil, and consulting a doctor about antidepressant side effects.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community My scalp punch biopsy results🤔?

      in Female  9 upvotes 2 years ago
      Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.

    Related Research

    3 / 3 results